
Moat Biotechnology
Developer of oral vaccines designed to accelerate the treatment of infectious diseases. The company holds an complete patent license for the novel second-generation single-cycle adenovirus vaccine pla...
Valuation
$0
Share Price
N/A
Total Raised
$8.2M
Last Round
N/A